You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LNP023

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatic Impairment Trial in San Antonio (Iptacopan)

Completed
  • Hepatic Impairment
  • San Antonio, Texas
    Novartis Investigative Site
Sep 20, 2022

C3 Glomerulopathy (C3G) Trial (Iptacopan)

Available
  • C3 Glomerulopathy (C3G)
  • (no location specified)
Jan 24, 2023

Glomerulonephritis Trial in Worldwide (LNP023)

Completed
Has Results
  • Glomerulonephritis
  • LNP023
  • Iowa City, Iowa
  • +8 more
Aug 8, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (LNP023)

Completed
  • Paroxysmal Nocturnal Hemoglobinuria
  • LNP023
  • Seoul, Korea, Republic of
  • +4 more
Apr 5, 2022

IC-MPGN Trial (Placebo, iptacopan)

Not yet recruiting
  • IC-MPGN
  • (no location specified)
Feb 23, 2023

Immune Thrombocytopenia (ITP), Cold Agglutinin Disease (CAD) Trial in Worldwide (Iptacopan)

Recruiting
  • Immune Thrombocytopenia (ITP)
  • Cold Agglutinin Disease (CAD)
  • Boston, Massachusetts
  • +11 more
Dec 15, 2022

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Iptacopan (LNP023))

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Iptacopan (LNP023)
  • Tianjin, Tianjin, China
  • +11 more
Nov 21, 2022

Atypical Hemolytic Uremic Syndrome Trial (Iptacopan)

Not yet recruiting
  • Atypical Hemolytic Uremic Syndrome
  • (no location specified)
Jun 29, 2023

Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Iptacopan)

Recruiting
  • Atypical Hemolytic Uremic Syndrome
  • Torrance, California
  • +19 more
Aug 10, 2022

Age-Related Macular Degeneration Trial in United States (Iptacopan (LNP023), Placebo)

Recruiting
  • Age-Related Macular Degeneration
  • Iptacopan (LNP023)
  • Placebo
  • Sacramento, California
  • +9 more
Sep 20, 2022

Atypical Hemolytic Uremic Syndrome Trial (Iptcaopan 200 mg)

Not yet recruiting
  • Atypical Hemolytic Uremic Syndrome
  • Iptcaopan 200 mg
  • (no location specified)
Mar 21, 2023

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (LNP023, Eculizumab, Ravulizumab)

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • LNP023
  • +2 more
  • Duarte, California
  • +39 more
Jan 13, 2023

Primary IgA Nephropathy Trial in Worldwide (LNP023)

Recruiting
  • Primary IgA Nephropathy
  • LNP023
  • Parkville, Victoria, Australia
  • +28 more
Jun 30, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Iptacopan)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Brno - Bohunice, Czechia
  • +30 more
Jul 29, 2022

IgA Nephropathy Trial in Worldwide (LNP023, Placebo)

Completed
  • IgA Nephropathy
  • LNP023
  • Placebo
  • Caba, Buenos Aires, Argentina
  • +55 more
Jul 7, 2021

C3G Trial in Worldwide (Placebo, iptacopan)

Recruiting
  • C3G
  • Aurora, Colorado
  • +60 more
Nov 23, 2022

IgA Nephropathy Trial in Worldwide (Placebo, LNP023)

Recruiting
  • IgA Nephropathy
  • Placebo
  • LNP023
  • Huntsville, Alabama
  • +193 more
Aug 10, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial (Iptacopan)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Nov 18, 2022